Trends in Abstinence and Retention Associated with a Medication-Assisted Treatment Program for People with Opioid Use Disorders

被引:1
|
作者
Brunisholz, Kimberly D. [1 ,2 ]
Knighton, Andrew [1 ]
Sharma, Amulya [3 ]
Nichols, Lisa [4 ]
Reisig, Kristen [3 ]
Burton, Jed [5 ]
Scovill, Debbie [6 ]
Tometich, Carolyn [6 ]
Foote, Mark [6 ]
Read, Shelly [6 ]
Whittle, Scott [7 ]
机构
[1] Intermountain Healthcare, Healthcare Delivery Inst, Salt Lake City, UT 84111 USA
[2] Univ Utah, Sch Med, Dept Internal Med, Div Epidemiol, Salt Lake City, UT 84112 USA
[3] Davis Behav Hlth, Davis, CA USA
[4] Intermt Healthcare, Community Hlth, Salt Lake City, UT USA
[5] Weber Human Serv, Ogden, UT USA
[6] Intermountain Healthcare, Behav Hlth Clin Program, Salt Lake City, UT USA
[7] SelectHealth, Murray, UT USA
关键词
Collective impact; Community-based participatory research; Health services; Medication-assisted treatment; Opioid use disorder; Preventive health services;
D O I
10.1353/cpr.2020.0002
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Background: Medication-assisted treatment (MAT) is an evidence-based program for patients with opioid use disorders. Yet, within the state of Utah, MAT had not been widely available, promoted, or adopted within the public sector. Recognizing the potential benefit, a collective impact approach was used to promote social change and increase the use of MAT in the community for treatment of opioid use disorders. Objective: Conduct a retrospective, observational case series study to measure the effect of a community-based, collective impact approach implementing the MAT program to improve the rate of abstinence and retention among individuals identified with an opioid use disorder in three Utah counties. Methods: The study was designed and implemented by the Utah Opioid Community Collaborative (OCC) using a collective impact approach, which included broad sector coordination (public-private collaboration), a common agenda, participation in mutually reinforcing activities, continuous communication, consistent measurement of results, and identification of a backbone organization. The MAT interventionprogram includes use of medications approved by the U.S. Food and Drug Administration in combination with counseling and behavioral therapies delivered within two community sites. Analysis was performed over time to describe the rate of abstinence and retention associated with participation in the MAT program during 2015 through 2017. Results: Of the 339 identified with risk of an opioid use disorders, 228 enrolled in the MAT Program. At MAT enrollment, average age was 32.6 } 8.2 years old and 58.0% were female. At 365 days after MAT enrollment, 84% of participants were abstinent from opioid substances and 62% from all illicit substances. Conclusions: Use of a collective impact approach provides a successful mobilization framework in Utah for increasing community engagement and expanding patient access to underresourced MAT programs while suggesting a high rate of abstinence from illicit substances at 12 months. © 2020 Johns Hopkins University Press.
引用
收藏
页码:5 / 6
页数:2
相关论文
共 50 条
  • [1] Medication-Assisted Treatment of Adolescents With Opioid Use Disorders
    Levy, Sharon
    Ryan, Sheryl A.
    Gonzalez, Pamela K.
    Patrick, Stephen W.
    Quigley, Joanna
    Siqueira, Lorena
    Walker, Leslie R.
    Faden, Vivian B.
    Tau, Gregory
    Jarrett, Renee
    [J]. PEDIATRICS, 2016, 138 (03)
  • [2] Opioid Use Disorders, Medication-Assisted Treatment, and the Role of the Laboratory
    Bertholf, Roger L.
    Reisfield, Gary M.
    [J]. LABORATORY MEDICINE, 2017, 48 (04) : E57 - E61
  • [3] Medication-assisted treatment for opioid use disorder
    Kaplan, Louise
    [J]. NURSE PRACTITIONER, 2019, 44 (03): : 10 - 12
  • [4] Evaluating Retention Rates in a Medication-Assisted Treatment Program
    Rioux, Jennifer
    Cuellar, Norma
    Oliver, JoAnn
    Hsu, Powen
    Szapkiw, Amanda
    [J]. JNP-JOURNAL FOR NURSE PRACTITIONERS, 2020, 16 (09): : E149 - E151
  • [5] Medication-assisted treatment for opioid use disorders in correctional settings: An ethics review
    Ludwig, Ariel S.
    Peters, Roger H.
    [J]. INTERNATIONAL JOURNAL OF DRUG POLICY, 2014, 25 (06) : 1041 - 1046
  • [6] Review of medication-assisted treatment for opioid use disorder
    Ghanem, Nessreen
    Dromgoole, Devin
    Hussein, Ahmad
    Jermyn, Richard T.
    [J]. JOURNAL OF OSTEOPATHIC MEDICINE, 2022, 122 (07): : 367 - 374
  • [7] Medication-Assisted Treatment for Opioid-Use Disorder
    Oesterle, Tyler S.
    Thusius, Nuna J.
    Rummans, Teresa A.
    Gold, Mark S.
    [J]. MAYO CLINIC PROCEEDINGS, 2019, 94 (10) : 2072 - 2086
  • [8] The NP and medication-assisted treatment for opioid use disorder
    Warner, Shirley A.
    Strickland, Daniel M.
    [J]. NURSE PRACTITIONER, 2022, 47 (07): : 10 - 13
  • [9] Integration of Medication-Assisted Treatment Information for Opioid Use Disorders Into a Graduate Nursing Curriculum
    Kameg, Brayden
    Kaufman, Robert
    Lindsay, Dawn
    Mitchell, Ann M.
    [J]. JOURNAL OF ADDICTIONS NURSING, 2018, 29 (03) : 163 - 166
  • [10] A community outreach intervention to link individuals with opioid use disorders to medication-assisted treatment
    Scott, Christy K.
    Dennis, Michael L.
    Grella, Christine E.
    Kurz, Rachel
    Sumpter, Jamie
    Nicholson, Lisa
    Funk, Rodney R.
    [J]. JOURNAL OF SUBSTANCE ABUSE TREATMENT, 2020, 108 : 75 - 81